SBC Medical Group’s (SBC) “Sell (D+)” Rating Reiterated at Weiss Ratings

by · The Cerbat Gem

Weiss Ratings reaffirmed their sell (d+) rating on shares of SBC Medical Group (NASDAQ:SBC – Free Report) in a report published on Tuesday,Weiss Ratings reports.

Separately, Wall Street Zen raised shares of SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, SBC Medical Group presently has an average rating of “Sell”.

Check Out Our Latest Analysis on SBC

SBC Medical Group Trading Down 1.4%

SBC opened at $4.17 on Tuesday. The firm has a market cap of $433.18 million, a price-to-earnings ratio of 13.03 and a beta of 1.29. SBC Medical Group has a 52 week low of $2.62 and a 52 week high of $8.10. The business’s 50 day moving average is $4.29 and its two-hundred day moving average is $4.23. The company has a quick ratio of 3.95, a current ratio of 3.98 and a debt-to-equity ratio of 0.03.

SBC Medical Group (NASDAQ:SBC – Get Free Report) last released its earnings results on Wednesday, August 13th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The company had revenue of $43.36 million during the quarter, compared to analyst estimates of $44.71 million. On average, research analysts predict that SBC Medical Group will post 5.02 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Geode Capital Management LLC acquired a new stake in SBC Medical Group in the second quarter valued at $455,000. New York State Common Retirement Fund purchased a new position in shares of SBC Medical Group in the 2nd quarter valued at about $104,000. XTX Topco Ltd acquired a new stake in shares of SBC Medical Group in the second quarter valued at about $64,000. Finally, SBI Securities Co. Ltd. boosted its holdings in SBC Medical Group by 227.3% during the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock worth $251,000 after buying an additional 37,623 shares in the last quarter. Hedge funds and other institutional investors own 60.82% of the company’s stock.

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.

Further Reading